CapsoVision Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	13.56	13.55	11.76	9.75
Revenue Growth (YoY)	12.61%	15.29%	20.54%	-
Cost of Revenue	6.56	6.38	5.38	4.26
Gross Profit	7.01	7.17	6.38	5.49
Selling, General & Admin	14.6	14.38	11.17	7.51
Research & Development	19.64	18.31	15.12	9.33
Total Operating Expenses	34.24	32.69	26.29	16.84
Operating Income	-27.23	-25.52	-19.92	-11.35
Interest Income	0.32	0.27	0.03	0.05
Other Non-Operating Income (Expense)	-0.04	-0.04	0	0
Total Non-Operating Income (Expense)	0.28	0.23	0.03	0.05
Pretax Income	-26.95	-25.29	-19.89	-11.29
Provision for Income Taxes	0.02	0.02	0.01	0.01
Net Income	-26.97	-25.32	-19.9	-11.31
Net Income to Common	-26.97	-25.32	-19.9	-11.31
Shares Outstanding (Basic)	36	25	2	2
Shares Outstanding (Diluted)	36	25	2	2
Shares Change (YoY)	1607.88%	1115.57%	14.74%	-
EPS (Basic)	-2.32	-1.03	-9.85	-6.43
EPS (Diluted)	-2.32	-1.03	-9.85	-6.43
Shares Outstanding	49.84	46.87	2.09	1.84
Free Cash Flow	-24.04	-22.95	-20.24	-11.56
Free Cash Flow Per Share	-0.67	-0.93	-10.02	-6.56
Gross Margin	51.67%	52.92%	54.24%	56.30%
Operating Margin	-200.75%	-188.25%	-169.42%	-116.34%
Profit Margin	-198.87%	-186.77%	-169.26%	-115.91%
FCF Margin	-177.26%	-169.35%	-172.20%	-118.49%
EBITDA	-26.65	-24.95	-19.4	-10.96
EBITDA Margin	-196.47%	-184.07%	-164.99%	-112.37%
EBIT	-27.23	-25.52	-19.92	-11.35
EBIT Margin	-200.75%	-188.25%	-169.42%	-116.34%
Effective Tax Rate	-0.09%	-0.09%	-0.06%	-0.10%

SEC Filings: 10-K · 10-Q